Binding Site’s Immunologicals Group is pleased to announce the introduction of a number of infectious | contagious disease state sera/plasma products to its broad portfolio

For the first time in the U.S., a blood test will be available to help doctors determine if people who've experienced a blow to the head could have a traumatic brain injury 

Researchers have shown for the first time that a tiny piece of RNA deregulates energy metabolism, an emerging hallmark of cancer

Insilico Medicine announced a research collaboration agreement with A2A Pharmaceuticals, Inc

Researchers have found that a thin membrane, thought to be just a shrink wrap around some bacterial cell walls, has structural properties critical for survival. 

New Scripps research study offers guidance for more effective Ebola vaccines

Researchers suggest that ZHX2 is a potential new therapeutic target for clear cell renal cell carcinoma, the most common type of kidney cancer

For the first time, a team of international researchers has mapped the family trees of cancer cells in acute myeloid leukaemia to understand how this blood cancer responds to a new drug, enasidenib

New technique detects mutations that affect large chunks of chromosomes in people with clonal hematopoiesis

Trial offers hope for new revaccination strategies with Bacille Calmette-Guerin (BCG) against Tuberculosis, the world's leading infectious disease killer